ZIOPHARM ONCOLOGY INC's ticker is and the CUSIP is 98973P951. A total of 3 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $19,176 | -18.2% | 37,600 | +1.1% | 0.00% | – |
| Q1 2023 | $23,436 | -8.1% | 37,200 | -5.3% | 0.00% | – |
| Q4 2022 | $25,510 | -92.2% | 39,300 | -79.4% | 0.00% | -100.0% |
| Q3 2022 | $329,000 | +40.6% | 191,100 | +1.2% | 0.00% | – |
| Q2 2022 | $234,000 | +154.3% | 188,800 | +34.6% | 0.00% | – |
| Q1 2022 | $92,000 | -42.1% | 140,300 | -3.7% | 0.00% | – |
| Q4 2021 | $159,000 | -51.2% | 145,700 | -18.7% | 0.00% | – |
| Q3 2021 | $326,000 | -11.9% | 179,300 | +28.0% | 0.00% | – |
| Q2 2021 | $370,000 | -25.3% | 140,100 | +1.8% | 0.00% | -100.0% |
| Q1 2021 | $495,000 | -15.1% | 137,600 | -40.5% | 0.00% | 0.0% |
| Q4 2020 | $583,000 | +109.0% | 231,400 | +109.2% | 0.00% | 0.0% |
| Q3 2020 | $279,000 | -28.8% | 110,600 | -7.4% | 0.00% | -50.0% |
| Q2 2020 | $392,000 | +4.0% | 119,500 | -22.4% | 0.00% | -33.3% |
| Q1 2020 | $377,000 | -82.8% | 154,000 | -66.8% | 0.00% | -80.0% |
| Q4 2019 | $2,186,000 | +0.4% | 463,200 | -9.0% | 0.02% | -16.7% |
| Q3 2019 | $2,178,000 | -6.6% | 508,900 | +27.2% | 0.02% | -14.3% |
| Q2 2019 | $2,333,000 | +109.4% | 400,200 | +38.3% | 0.02% | +75.0% |
| Q1 2019 | $1,114,000 | +81.4% | 289,300 | -11.9% | 0.01% | +140.0% |
| Q4 2018 | $614,000 | -51.5% | 328,300 | -17.0% | 0.01% | -50.0% |
| Q3 2018 | $1,266,000 | +4.7% | 395,500 | -1.2% | 0.01% | 0.0% |
| Q2 2018 | $1,209,000 | +25.9% | 400,300 | +63.4% | 0.01% | 0.0% |
| Q1 2018 | $960,000 | -30.0% | 245,000 | -26.0% | 0.01% | 0.0% |
| Q4 2017 | $1,371,000 | -21.7% | 331,100 | +16.1% | 0.01% | -37.5% |
| Q3 2017 | $1,751,000 | -14.7% | 285,200 | -13.6% | 0.02% | -23.8% |
| Q2 2017 | $2,053,000 | +15.3% | 330,100 | +17.6% | 0.02% | 0.0% |
| Q1 2017 | $1,780,000 | -31.8% | 280,800 | -42.5% | 0.02% | -16.0% |
| Q4 2016 | $2,611,000 | +16.5% | 488,100 | +22.6% | 0.02% | +4.2% |
| Q3 2016 | $2,242,000 | -31.8% | 398,200 | -33.5% | 0.02% | -38.5% |
| Q2 2016 | $3,285,000 | +8.3% | 598,400 | +46.4% | 0.04% | -9.3% |
| Q1 2016 | $3,033,000 | -37.2% | 408,700 | -29.7% | 0.04% | -24.6% |
| Q4 2015 | $4,829,000 | -12.4% | 581,100 | -5.0% | 0.06% | -25.0% |
| Q3 2015 | $5,513,000 | -43.5% | 611,900 | -24.8% | 0.08% | -44.5% |
| Q2 2015 | $9,758,000 | +36.5% | 813,200 | +22.5% | 0.14% | +22.3% |
| Q1 2015 | $7,150,000 | +400.0% | 663,900 | +135.4% | 0.11% | +409.1% |
| Q4 2014 | $1,430,000 | +113.4% | 282,000 | +11.2% | 0.02% | +120.0% |
| Q3 2014 | $670,000 | -40.5% | 253,600 | -9.2% | 0.01% | -41.2% |
| Q2 2014 | $1,126,000 | -4.3% | 279,300 | +8.8% | 0.02% | -15.0% |
| Q1 2014 | $1,176,000 | -35.1% | 256,700 | -38.5% | 0.02% | -25.9% |
| Q4 2013 | $1,812,000 | +122.3% | 417,500 | +102.3% | 0.03% | +68.8% |
| Q3 2013 | $815,000 | +74.9% | 206,400 | -6.9% | 0.02% | +45.5% |
| Q2 2013 | $466,000 | – | 221,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIMPLEX TRADING, LLC | 137,600 | $375,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 179,300 | $326,000 | 0.00% |